NSAIDs vs. Coxibs in the Presence of Aspirin

Stopped Our group moved from Inova Heart and Vascular institute to Sinai Hospital with Platelet and Thrombosis, LLC taking over sponsorship. Study was then IRB approved at Sinai on March, 2020 but closed prior to any additional enrolment due to COVID.

Conditions

• Rheumatoid Arthritis
• Cardiovascular Diseases

Interventions

• DRUG: celecoxib 200mg capsule
• DRUG: naproxen sodium 550mg tablet
• DRUG: Aspirin 81mg tablet

Sponsor

Platelet and Thrombosis Research, LLC